Cancer

January 17, 2013

Study helps define pancreatic cancer’s cellular origins

Vanderbilt and University of California investigators have discovered the “cell of origin” for pancreatic ductal adenocarcinoma, a finding that could lead to early detection methods and new treatments.

By Leigh MacMillan
January 10, 2013

Three new genetic links to colorectal cancer revealed

Vanderbilt-Ingram Cancer Center investigators have identified three new genetic “hotspots” linked to colorectal cancer.

By VUMC News and Communications
January 10, 2013

Pancreas Center coordinates care for complex cases

Patients with pancreatic diseases can now access a team of multi-disciplinary specialists with one phone call to the new Vanderbilt Pancreas Center.

By Leigh MacMillan
December 24, 2012

A drug combo for ovarian cancer

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.

By Leigh MacMillan
December 20, 2012

Cancer markers from archived tissue

Archived tissue samples are yielding new disease biomarkers.

By VUMC News and Communications
December 7, 2012

Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators.

By VUMC News and Communications
November 29, 2012

Polarity protein suppresses tumor growth, invasion

The machinery that builds the characteristic shape of epithelial cells suppresses breast cancer formation and metastasis in a mouse model.
By Leigh MacMillan
November 28, 2012

New faculty: Jie Deng’s care for patients inspires lymphedema research

By VUMC News and Communications
November 15, 2012

Study tracks antioxidants’ role in prostate tumor growth

Antioxidants promote cell growth in a mouse model of prostate cancer, Vanderbilt researchers report in the journal PLoS ONE. The findings provide insight into the recent controversy regarding antioxidants and prostate cancer prevention.
By Leigh MacMillan
November 8, 2012

Events set to bolster lung cancer research

More Tennesseans are expected to die this year from lung cancer than any other form of cancer, yet lung cancer research receives far less funding than other forms of the disease.
By VUMC News and Communications
October 31, 2012

Green tea found to reduce rate of some GI cancers

Green tea may lower risk of some digestive cancers.
By VUMC News and Communications
October 25, 2012

Combined drug therapy may delay melanoma progression

Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene.
By VUMC News and Communications
October 23, 2012

Stomach bug alters tumor suppressor

The stomach bug Helicobacter pylori increases forms of a protein that promote tumor development, perhaps explaining how it elevates risk for gastric cancer.
By Leigh MacMillan